Meghalaya Chief Minister Conrad K Sangma on Friday said the Centre should ensure that there is no "illegal activity" in the North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS).
NEIGRIHMS has been embroiled in controversy following allegations by its director D M Thappa against the cardiology department head for not cooperating with the administration in making treatment of poor patients affordable.
Thappa had also said complaints were received regarding the high price of heart stents availed from local vendors, instead of the AMRIT pharmacy at the institute.
"As a concerned citizen and as the head of the state, if there is any kind of illegal activity that is going on (NEIGRIHMS), it must be enquired into by the government of India," Sangma told reporters here.
He added that the state government does not have much say in the affairs of the central institute except to flag issues to the Union government.
Earlier, the NEIGRIHMS director had sought the intervention of Prime Minister Narendra Modi for a CBI inquiry into the alleged nexus between the cardiology department and a private pharmacy.
The Meghalaya Pradesh Youth Congress (MPYC) and the Civil Society Women's Organisation (CSWO) have also demanded a probe by the central investigating agency.
In May, authorities at the institute had seized various cardiology stents, worth over Rs 20 lakh, from a vendor in the premises of the hospital.
The stents were allegedly sold at a higher price than the capped rate fixed by the ministry at Rs 30,000.
The Cardiology department head, however, denied the allegations and claimed that the Amrit pharmacy had indicated about the non-availability of stents.
NEIGRIHMS is the only super specialty hospital in the northeast region.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
